Document Detail


Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data.
MedLine Citation:
PMID:  9790483     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Chronic fatigue syndrome (CFS) has been widely studied by neuroimaging techniques in recent years with conflicting results. In particular, using single-photon emission computed tomography (SPECT) and perfusion tracers, hypoperfusion has been found in several brain regions, although the findings vary across research centers. The objective of this study was to investigate brain metabolism of patients affected by CFS, using [18F]fluorine-deoxyglucose (18FDG) positron emission tomography (PET). We performed 18FDG PET in 18 patients who fulfilled the criteria of the working case definition of CFS. Twelve of the 18 patients were females; the mean age was 34 +/- 15 years (range, 15-68) and the median time from CFS diagnosis was 16 months (range, 9-138). Psychiatric diseases and anxiety/neurosis were excluded in all CFS patients. CFS patients were compared with a group of 6 patients affected by depression (according to DSM IV-R) and 6 age-matched healthy controls. The CFS patients were not taking any medication at the time of PET, and depressed patients were drug-free for at least 1 week before the PET examination. The PET images examined 22 cortical and subcortical areas. CFS patients showed a significant hypometabolism in right mediofrontal cortex (P = 0.010) and brainstem (P = 0.013) in comparison with the healthy controls. Moreover, comparing patients affected by CFS and depression, the latter group showed a significant and severe hypometabolism of the medial and upper frontal regions bilaterally (P = 0.037-0.001), whereas the metabolism of brain stem was normal. Brain 18FDG PET showed specific metabolism abnormalities in patients with CFS in comparison with both healthy controls and depressed patients. The most relevant result of our study is the brain stem hypometabolism which, as reported in a perfusion SPECT study, seems to be a marker for the in vivo diagnosis of CFS.
Authors:
U Tirelli; F Chierichetti; M Tavio; C Simonelli; G Bianchin; P Zanco; G Ferlin
Related Documents :
6622853 - Cystic fibrosis related lung diseases in young adults with minimal impairment.
15085023 - Serum lipase after secretin stimulation detects mild pancreatic involvement in cystic f...
15620493 - Trial pinning prior to wrist arthrodesis in children.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The American journal of medicine     Volume:  105     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1998 Sep 
Date Detail:
Created Date:  1998-11-06     Completed Date:  1998-11-06     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  54S-58S     Citation Subset:  AIM; IM    
Affiliation:
Division of Medical Oncology and Acquired Immunodeficiency Syndrome, Centro di Riferimento Oncologico, Aviano, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Brain / radionuclide imaging*
Case-Control Studies
Fatigue Syndrome, Chronic / radionuclide imaging*
Female
Fluorodeoxyglucose F18 / diagnostic use
Humans
Male
Middle Aged
Radiopharmaceuticals / diagnostic use
Tomography, Emission-Computed*
Chemical
Reg. No./Substance:
0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Neuroimaging in chronic fatigue syndrome.
Next Document:  Influence of exhaustive treadmill exercise on cognitive functioning in chronic fatigue syndrome.